NOVAVAX INC — Director's Dealing 2017

Aug 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2017-07-31

Reporting Person: PHILLIPS BARCLAY A (SVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-31	Common Stock	P	2057	$0.89	Acquired	38669	Direct

Footnotes

F1: Includes 2,057 shares acquired under the Issuer's Amended and Restated 2013 Employee Stock Purchase Plan on July 31, 2017.